Results 211 to 220 of about 6,578,993 (340)

Assessment tools for peripheral neuropathy in multiple myeloma. [PDF]

Korean J Intern Med
Park SS, Kwak K, Baek SH, Kim C, Choi YS, Park Y, Kim BS, Kim JS, Min CK, Kang KW.   +9 more
europepmc   +1 more source

Posterior Reversible Encephalopathy Syndrome in a Patient with Multiple System Atrophy and Multiple Myeloma

Movement Disorders Clinical Practice, EarlyView.
Jackson Mitzner, Jenny Linnoila, Yanal Shaheen, Abby L. Olsen   +3 more
wiley   +1 more source

Patients', clinicians' and research's priorities on important outcomes in multiple myeloma: A mixed‐methods study

British Journal of Haematology, EarlyView.
Summary Research in multiple myeloma increasingly relies on surrogate end‐points to expedite approvals, yet these may not reflect patient priorities. We conducted a mixed‐methods study to identify outcomes valued by patients and clinicians and compare them with end‐points used in randomized controlled trials (RCTs).
Maria Mainou, Thomas Karagiannis, Eirini Pagkalidou, Aris Liakos, Panagiotis Malandrakis, Evdoxia Hatjiharissi, Sofia Chissan, Evdokia Mandala, Oliver Van Oekelen, Efthymia Vlachaki, Maria Papaioannou, Evangelos Terpos, Ghulam Rehman Mohyuddin, Apostolos Tsapas   +13 more
wiley   +1 more source

Advances in multiple myeloma: key updates from the ASH 2025 meeting. [PDF]

J Hematol Oncol
Naing PT, Baljevic M.
europepmc   +1 more source

Family history of haematological malignancy and prognosis across non‐Hodgkin lymphoma subtypes

British Journal of Haematology, EarlyView.
Multivariable‐adjusted associations between family history of haematological malignancy (FHHM) and survival outcomes by non‐Hodgkin lymphoma subtype [OS (A), EFS (B), LSS (C) and failure to achieve EFS at 24 months (D)]. Subtype‐specific analyses showed that FHHM was associated with significantly inferior EFS in MCL and inferior LSS in FL.
George A. Cholack, Raphael Mwangi, Prokop Vodička, Thomas M. Habermann, Verena Hinder, Dennis P. Robinson, Andrew L. Feldman, Thomas E. Witzig, Jose C. Villasboas, Stephen M. Ansell, Brian K. Link, Yucai Wang, Carrie A. Thompson, Susan L. Slager, Matthew Maurer, Anne J. Novak, James R. Cerhan   +16 more
wiley   +1 more source

Leveraging paired germline and somatic analysis to improve the classification of DDX41 variants

British Journal of Haematology, EarlyView.
Summary Constitutional pathogenic variants in DDX41 predispose to myelodysplasia and acute myeloid leukaemia. Acquisition of subsequent somatic hits in the second allele is frequent, with notable recurrent variants at key hotspots. Sequencing of Deoxyribonucleic acid from blood/marrow of 239 patients with suspected/confirmed haematological malignancies
Andrew George, Elisabeth Rolf, Monika Domeradzka, Sara Ribeiro, Brittany Mills, April Hallett, Suzanne Macmahon, Paula Proszek, Ridwan Shaikh, Lina Yuan, Michael Hubank, Mikel Valganon Petrizan, Terri P. McVeigh, Jamshid S. Khorashad   +13 more
wiley   +1 more source

Sleep quality and sleepiness in adults with multiple myeloma. Is melatonin a potential treatment? [PDF]

Physiol Rep
Fiori M, de Azevedo EM, Rodrigues LS, Turt KS, Bruschi DP, Lima MMS.   +5 more
europepmc   +1 more source

Renal dysfunction in symptomatic Waldenström macroglobulinaemia: A nationwide Italian multicentre study

British Journal of Haematology, EarlyView.
Renal dysfunction represents a possible underrecognized complication of symptomatic WM; this condition correlates with adverse global and disease‐specific clinical outcomes. Summary The prognostic significance of impaired renal function in Waldenström macroglobulinaemia (WM) remains poorly defined.
Nicolò Danesin, Francesco Autore, Anna Maria Frustaci, Gianmarco Favrin, Emanuele Cencini, Alessandro Noto, Irene Dogliotti, Jacopo Olivieri, Marcello Riva, Isacco Ferrarini, Anna Maria Barbui, Sara Steffanoni, Dario Marino, Benedetta Puccini, Piero Maria Stefani, Rita Rizzi, Michele Merli, Angela Ferrari, Stefano Luminari, Carlo Visco, Livio Trentin, Andrea Visentin, Annarita Conconi, Simone Ferrero, Marzia Varettoni, Alessandra Tedeschi, Luca Laurenti, Francesco Piazza   +27 more
wiley   +1 more source

Plerixafor plus granulocyte colony-stimulating factor for patients with non-Hodgkin lymphoma and multiple myeloma: Long-term follow-up report [PDF]

, 2018
Bolwell, Brian, Cheverton, Peter D, DiPersio, John F, Horwitz, Mitchell E, Kaufman, Jonathan L, Maziarz, Richard T, McCarty, John M, Micallef, Ivana N, Nademanee, Auayporn P, Stadtmauer, Edward A, Stiff, Patrick J, Struijs, Martin, Vargo, Rita   +12 more
core   +2 more sources

MULTIPLE MYELOMA [PDF]

BMJ, 1907
J R, Charles, H H, Sanguinetti
openaire   +2 more sources